Literature DB >> 27450163

[Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system].

Carmelo Aguirre1, Montserrat García2.   

Abstract

Mesh：

Year:  2016        PMID： 27450163     DOI： 10.1016/j.medcli.2016.06.012

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  16 in total

1.  New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib - A Case Report.

Authors:  Eudald Felip; Laia Llobera; Clara Perez-Mañá; David Quintela; Ignacio Guasch; Mireia Margelí; Iris Teruel; Beatriz Cirauqui; Carmen Centeno; Margarita Romeo; Ester Ballana; Vanesa Quiroga
Journal:  Breast Care (Basel)       Date:  2019-12-18       Impact factor: 2.860

2.  Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents.

Authors:  Pablo Montejano-Hervás; Javier Gómez-Pavón; Olga Tornero-Torres; Mª Victoria Valverde-Moyar; Beatriz Martín Cruz; Maribel Vela Carbonera; Raquel Fuentes-Irigoyen; Pilar Tejada González; Margarita González-Becerra; Esther Higueras Sánchez; Primitivo Ramos Cordero
Journal:  Drugs Aging       Date:  2022-07-07       Impact factor: 4.271

3.  Suspected adverse events following immunization against SARS-CoV2 in a university hospital in 2021: Observational study.

Authors:  Dolores Rodríguez; Pilar Ordoñez; Roser Llop; Sebastián Videla; Aurema Otero; Thiago Carnaval; Violeta Poltorak; Miguel Moya-Guerola; Cristina Masuet-Aumatell; Soledad Rodriguez; Pilar Hereu
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

4.  Atypical Fracture of the Sternum After Long-Term Alendronate Plus Cholecalciferol Treatment: A Case Report.

Authors:  Luis H Martín Arias; Pilar García Ortega; María Sáinz Gil; Ester Navarro García; Carlos Treceño Lobato; Virginia Delgado Armas
Journal:  Drug Saf Case Rep       Date:  2017-12

5.  Urgent Hospital Admissions Caused by Adverse Drug Reactions and Medication Errors-A Population-Based Study in Spain.

Authors:  Gina Mejía; Miriam Saiz-Rodríguez; Beatriz Gómez de Olea; Dolores Ochoa; Francisco Abad-Santos
Journal:  Front Pharmacol       Date:  2020-05-21       Impact factor: 5.810

6.  Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.

Authors:  Elena Ramírez; Mikel Urroz; Amelia Rodríguez; Miguel González-Muñoz; Alberto Martín-Vega; Yuri Villán; Enrique Seco; Jaime Monserrat; Jesús Frías; Antonio J Carcas; Alberto M Borobia
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

7.  Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database.

Authors:  Luis H Martín; María Sainz-Gil; Ester Navarro-García; Inés Salado-Valdivieso; Rosario Sanz-Fadrique
Journal:  Drugs Real World Outcomes       Date:  2022-02-10

8.  Spontaneous Reporting of Adverse Drug Reactions in a Pediatric Population in a Tertiary Hospital.

Authors:  Laura López-Valverde; Èlia Domènech; Marc Roguera; Ignasi Gich; Magí Farré; Carlos Rodrigo; Eva Montané
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

9.  SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability.

Authors:  Pablo Zubiaur; Maria Dolores Benedicto; Gonzalo Villapalos-García; Marcos Navares-Gómez; Gina Mejía-Abril; Manuel Román; Samuel Martín-Vílchez; Dolores Ochoa; Francisco Abad-Santos
Journal:  J Pers Med       Date:  2021-03-13

10.  SARS-CoV-2, skin lesions and the need of a multidisciplinary approach.

Authors:  R Cabrera-Hernández; E Solano-Solares; V Chica-Guzmán; M Fernández-Guarino; D Fernández-Nieto; D Ortega-Quijano; A de-Andrés-Martín; C Moreno; I Carretero-Barrio; P García-Abellás; D González-de-Olano; B de-la-Hoz-Caballer
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-02       Impact factor: 9.228
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.